This presentation will summarize prevention and treatment recommendations from the new ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder. Key takeaways from the guideline will be discussed. Topics for discussion will include behavioral and pharmacological treatments, co-occurring conditions, management of stimulant intoxication and withdrawal, and secondary and tertiary prevention strategies to reduce harms associated with risky stimulant use.
Learning Objectives:
Learners will be able to:
Apply the key clinical takeaways for the treatment of StUD based upon the ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
Recognize the importance of strategies to reduce harms related to risky stimulant use
